DYM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.826600E-01
Normal-vs-Stage2
3.254800E-01
Normal-vs-Stage3
1.273210E-01
Normal-vs-Stage4
8.791800E-01
Stage1-vs-Stage2
4.790400E-01
Stage1-vs-Stage3
7.757800E-01
Stage1-vs-Stage4
3.332000E-01
Stage2-vs-Stage3
3.634400E-01
Stage2-vs-Stage4
3.936000E-01
Stage3-vs-Stage4
1.977990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.498800E-01
Normal-vs-AfricanAmerican
9.660200E-01
Normal-vs-Asian
9.608100E-02
Caucasian-vs-AfricanAmerican
9.207900E-02
Caucasian-vs-Asian
2.480500E-02
AfricanAmerican-vs-Asian
4.685900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.305600E-01
Normal-vs-Female
3.620000E-01
Male-vs-Female
3.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.551600E-01
Normal-vs-Age(41-60Yrs)
5.137600E-01
Normal-vs-Age(61-80Yrs)
2.141200E-01
Normal-vs-Age(81-100Yrs)
2.446600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.414590E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.535200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.018000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.945800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.690000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.563500E-02
Normal-vs-Daily Drinker
1.010180E-02
Normal-vs-Weekly Drinker
5.765200E-01
Normal-vs-Occasional Drinker
3.775800E-01
Normal-vs-Social Drinker
7.588400E-01
Non Drinker-vs-Daily Drinker
1.269170E-01
Non Drinker-vs-Weekly Drinker
2.487800E-01
Non Drinker-vs-Occasional Drinker
2.795400E-01
Non Drinker-vs-Social Drinker
2.656300E-02
Daily Drinker-vs-Weekly Drinker
7.198100E-02
Daily Drinker-vs-Occasional Drinker
4.940500E-02
Daily Drinker-vs-Social Drinker
3.541600E-03
Weekly Drinker-vs-Occasional Drinker
7.491600E-01
Weekly Drinker-vs-Social Drinker
5.560400E-01
Occasional Drinker-vs-Social Drinker
2.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.223200E-01
Normal-vs-Grade 2
8.372000E-01
Normal-vs-Grade 3
8.825600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.972400E-01
Grade 1-vs-Grade 3
3.920600E-01
Grade 1-vs-Grade 4
8.223200E-01
Grade 2-vs-Grade 3
3.622600E-01
Grade 2-vs-Grade 4
8.372000E-01
Grade 3-vs-Grade 4
8.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.434000E-01
Normal-vs-NonDiabetic
1.797550E-01
Diabetic-vs-NonDiabetic
4.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.655610E-01
Normal-vs-NoPancreatitis
2.168600E-01
Pancreatitis-vs-NoPancreatitis
6.644600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.549400E-01
Normal-vs-N1
3.736000E-01
N0-vs-N1
1.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.566800E-01
Normal-vs-TP53-NonMutant
3.998200E-01
TP53-Mutant-vs-TP53-NonMutant
3.612400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
